These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30173227)

  • 1. CD56 expression in benign and malignant thyroid lesions.
    Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N
    Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HBME-1 and CD56 in follicular variant of papillary carcinoma in children: An immunohistochemical study and their diagnostic utility.
    Skaria PE; Ahmed AA; Yin H; Nicol K; Reid KJ; Singh V
    Pathol Res Pract; 2019 May; 215(5):880-884. PubMed ID: 30711197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
    Pyo JS; Kim DH; Yang J
    Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of CD56 and nm23 markers in papillary thyroid carcinoma.
    Shahebrahimi K; Madani SH; Fazaeli AR; Khazaei S; Kanani M; Keshavarz A
    Indian J Pathol Microbiol; 2013; 56(1):2-5. PubMed ID: 23924549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the diagnostic value of emerin and CD56 in papillary thyroid carcinoma - an immunohistochemical study.
    Abdou AG; Abdelwahed M; Said A; Taie DM; Fahmy S
    J Immunoassay Immunochem; 2018; 39(5):521-537. PubMed ID: 30188764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The absence of CD56 expression can differentiate papillary thyroid carcinoma from other thyroid lesions.
    Golu I; Vlad MM; Dema A; Moleriu LC; Tudor A; Iacob M; Popa O; Cornianu M
    Indian J Pathol Microbiol; 2017; 60(2):161-166. PubMed ID: 28631628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
    Abouhashem NS; Talaat SM
    Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
    Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
    Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of HBME-1, E-cadherin, and CD56 in the differential diagnosis of thyroid nodules.
    Ozolins A; Narbuts Z; Strumfa I; Volanska G; Stepanovs K; Gardovskis J
    Medicina (Kaunas); 2012; 48(10):507-14. PubMed ID: 23324246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary thyroid tumors: Diagnostic value of CD56 and Cytokeratin 19.
    Zehani A; Bani A; Chelly I; Rejaibi S; Besbes G; Haouet S; Kchir N
    Tunis Med; 2018 Feb; 96(2):113-121. PubMed ID: 30324976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.
    El Demellawy D; Nasr AL; Babay S; Alowami S
    Pathol Res Pract; 2009; 205(5):303-9. PubMed ID: 19153015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature.
    Dunđerović D; Lipkovski JM; Boričic I; Soldatović I; Božic V; Cvejić D; Tatić S
    Diagn Pathol; 2015 Oct; 10():196. PubMed ID: 26503236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of immunohistochemical panel in various thyroid pathologies.
    Ozolins A; Narbuts Z; Strumfa I; Volanska G; Gardovskis J
    Langenbecks Arch Surg; 2010 Sep; 395(7):885-91. PubMed ID: 20640858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.
    Elsers DA; Hussein MRA; Osman MH; Mohamed GA; Hosny G
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3365-3376. PubMed ID: 34711014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma.
    Yang X; Hu Y; Shi H; Zhang C; Wang Z; Liu X; Chen H; Zhang L; Cui D
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2127-2134. PubMed ID: 29951933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of HBME-1, CK19, Galectin 3, and CD56 in the subtypes of follicular variant of papillary thyroid carcinoma.
    Cho H; Kim JY; Oh YL
    Pathol Int; 2018 Nov; 68(11):605-613. PubMed ID: 30350394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of HBME-1, CD56, Galectin-3 and Cytokeratin-19 in papillary thyroid carcinomas and thyroid tumors of uncertain malignant potential.
    Nechifor-Boilă A; Cătană R; Loghin A; Radu TG; Borda A
    Rom J Morphol Embryol; 2014; 55(1):49-56. PubMed ID: 24715165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.